Bone Biologics (BBLG) Net Margin (2016 - 2017)
Historic Net Margin for Bone Biologics (BBLG) over the last 2 years, with Q4 2017 value amounting to 189.83%.
- Bone Biologics' Net Margin changed N/A to 189.83% in Q4 2017 from the same period last year, while for Dec 2017 it was 159.42%, marking a year-over-year decrease of 23478100.0%. This contributed to the annual value of 200.06% for FY2021, which is 172400.0% up from last year.
- As of Q4 2017, Bone Biologics' Net Margin stood at 189.83%.
- Bone Biologics' 5-year Net Margin high stood at 3954.93% for Q1 2016, and its period low was 106.19% during Q2 2017.